Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an investigational treatment.
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an investigational treatment.
COPD flare-ups can be stressful and may make breathing even harder. Many people still experience flare-ups even while using their daily inhalers.
This research study is looking at an investigational injectable medication. The purpose is to learn whether targeting a specific type of inflammation found in some people with COPD may help reduce future flare-ups.
Participants will continue using their regular COPD inhalers throughout the study.
You may be able to join if you:
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a
Adults 18 to 65 years of age with Major Depressive Disorder (MDD) may qualify for a clinical research study evaluating
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational